37 completed, 23 recruiting, 18 unknown, 12 terminated. 113 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 113 | Completed 37, Recruiting 23, Unknown 18, Terminated 12, Not yet recruiting 10, Active not recruiting 9, Withdrawn 3, Enrolling by invitation 1 |
Follow Acute Myeloid Leukemia: new trials by email Literature Review of Acute Myeloid Leukemia trials Research Report on Acute Myeloid Leukemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Feasibility and Efficiency Study for the Implementation of a New Screening Method for Patients With Acute Myeloid Leukemia, in Laboratory Practice Bone marrow or peripheral blood withdrawal for test comparison - Acute Myeloid Leukemia, Acute Myeloid Leukemia, Adult | Not applicable | Not yet recruiting | Gruppo Italiano Malattie EMatologiche dell'Adulto | 75 | 2027-01-01 | 2026-10-09 |
| Prevention of Oral Mucositis in Adults in With Hematologic Malignancy Aloe Vera Mouthwash, Standard of Care - Acute Leukemia, Acute Myeloid Leukemia | Not applicable | Not yet recruiting | Wake Forest University Health Sciences | 206 | 2027-01-01 | 2026-10-22 |
| Study to Characterize Mismatched to Fully HLA-Matched Ossium HPC, Marrow and Living Donor Transplantation in Patients With Hematologic Malignancies Ossium HPC, Marrow, Standard of care living donor - Haplo Related, Standard of care living donor - Mismatched Unrelated - Hematologic Malignancy, Acute Leukemia | Not applicable | Not yet recruiting | Ossium Health, Inc. | 300 | 2026-12-01 | 2026-09-10 |
| Digital Patient-Reported Assessment in Older Adults With Acute Leukemia Digital Patient-Reported Assessment Pathway - Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia | Not applicable | Not yet recruiting | Fundación para la Investigación Biosanitaria del Principado de Asturias | 20 | 2026-12-01 | 2026-10-07 |
| A Home-Based Exercise Intervention (CAREFit-BMT) in Improving Heart Function Among Patients With High Risk Acute Myeloid Leukemia Undergoing Stem Cell Transplant Aerobic Exercise, Resistance Training, Biospecimen Collection - Acute Myeloid Leukemia | Not applicable | Recruiting | University of Washington | 30 | 2026-12-01 | 2026-10-29 |
| my.naviGATE: A Guide to After-Treatment Effects for Adolescents and Young Adults my.naviGATE Digital Tool - Sarcoma, Osteosarcoma | Not applicable | Not yet recruiting | Dana-Farber Cancer Institute | 143 | 2026-11-20 | 2026-10-29 |
| MAC vs RIC for Transplantation in FLT3-ITD-Mutated AML Guided by UHS-NGS MRD ( FLT3 - MAC vs RIC ) RIC, MAC - ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION, Acute Myeloid Leukemia | Not applicable | Not yet recruiting | First Affiliated Hospital of Zhejiang University | 310 | 2026-11-01 | 2026-10-29 |
| Randomization for the Identification of Best Treatment Intensity for Less Fit Adults With Acute Myeloid Leukemia and Myeloid Neoplasms Biospecimen Collection, Bone Marrow Collection, Electronic Health Record Review - Acute Leukemia of Ambiguous Lineage, Acute Myeloid Leukemia | Not applicable | Recruiting | Fred Hutchinson Cancer Center | 50 | 2026-10-13 | 2026-10-19 |
| TBF Conditioning Regimen for Haploidentical Stem Cell Transplantation in Elderly AML Patients in First Complete Remission Thiotepa, Busulfan (BU), Fludarabine - Acute Myeloid Leukemia | Not applicable | Not yet recruiting | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | 93 | 2026-06-01 | 2026-05-04 |
| Effect of Hypnosis and Virtual Reality on Anxiety During Treatment for Acute Myeloid Leukemia Hypnosis, Virtual Reality - Acute Myeloid Leukemia | Not applicable | Not yet recruiting | University Hospital, Toulouse | 99 | 2026-02-01 | 2026-02-04 |
| Study of the Relationship Between the Pharmacokinetics (PK) and Pharmacodynamics of Venetoclax in Patients With Acute Myeloblastic Leukemia Pharmacokinetic dosages of venetoclax - Acute Myeloid Leukemia | Not applicable | Recruiting | Centre Leon Berard | 100 | 2026-01-21 | 2026-05-08 |
| Pre-DLI or Pro-DLI in Relapsed/Refractory Myeloid Neoplasms After HSCT Prophylactic DLI, Preemptive DLI - Acute Myeloid Leukemia, Myelodysplastic Syndromes (MDS) | Not applicable | Not yet recruiting | Peking University People's Hospital | 200 | 2026-01-01 | 2026-01-06 |
| Evaluating the Effects of Hemoglobin Threshold-specific Packed Red Blood Cell Transfusions on Quality of Life and Functional Outcomes in Patients With High-grade Myeloid Neoplasms, Acute Myeloid Leukemia, or B Acute Lymphoblastic Lymphoma/Leukemia Activity Tracking, Biospecimen Collection, Cognitive Assessment - Acute Myeloid Leukemia, B Acute Lymphoblastic Leukemia | Not applicable | Recruiting | University of Washington | 50 | 2025-10-15 | 2026-08-19 |
| Molecular Characterization of Carbapenemase-Producing Enterobacterales Antibiotic administration, Molecular detection of antibiotic resistance - Acute Myeloid Leukemia | Not applicable | Not yet recruiting | Sohag University | 100 | 2025-09-10 | 2025-08-11 |
| Venetoclax-Enhanced BUCY vs. Standard BUCY Conditioning in High-Risk AML and MDS Patients Undergoing Allo-HSCT (Ven-BUCY Study) Venetoclax, None-placebo, Busulfan (BU) - Acute Myeloid Leukemia, High-Risk Acute Myeloid Leukemia | Not applicable | Recruiting | First Affiliated Hospital of Zhejiang University | 138 | 2025-08-20 | 2026-09-02 |
| ONC-LEUK-2406: The Impact of Systematic Financial Navigation in Acute Myeloid Leukemia Arm A, Arm B - Acute Myeloid Leukemia | Not applicable | Recruiting | Wake Forest University Health Sciences | 120 | 2025-06-27 | 2026-07-23 |
| Home Blood Transfusions Home Blood Transfusion - Hematologic Malignancy, Myelodysplastic Syndromes | Not applicable | Recruiting | Thomas Jefferson University | 30 | 2025-06-03 | 2025-12-16 |
| TCRαβ/CD19 Depletion of Stem Cell Grafts for Transplant CliniMACS® device - Graft Vs Host Disease, Graft-versus-host-disease | Not applicable | Withdrawn | Neena Kapoor, M.D. | 2025-05-27 | 2025-07-14 | |
| Extension Study, Pilot, Compassionate Use of Azacitidine 300 mg Film Coated Tablets for Acute Myeloid Leukaemia (AML) Patients Azacitidine - Acute Myeloid Leukemia | Not applicable | Active not recruiting | Hikma Pharmaceuticals LLC | 20 | 2025-04-29 | 2026-01-14 |
| Daunorubicin + Cytarabine + Venetoclax in de Novo AML (Daunorubicin, Cytarabine, Venetoclax), (Daunorubicin, Cytarabine) - Leukemia, Myeloid, Acute, Acute Myeloid Leukemia | Not applicable | Enrolling by invitation | Anhui Medical University | 94 | 2025-02-01 | 2025-05-14 |
Showing 20 of 113. Sign in to see all of them.
Leukemia, Myeloid, Acute (113) · Myelodysplastic Syndromes (24) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (22) · Hodgkin Disease (9) · Lymphoma, Non-Hodgkin (8) · Leukemia (7) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (7) · Multiple Myeloma (7) · Hematologic Neoplasms (6) · Lymphoma (5) · Primary Myelofibrosis (5) · Leukemia, Lymphocytic, Chronic, B-Cell (4) · Myeloproliferative Disorders (4) · Recurrence (4) · Anemia, Refractory, with Excess of Blasts (3)
Hemic and Lymphatic Diseases (113) · Leukemia, Myeloid (113) · Neoplasms by Histologic Type (113) · Hematologic Diseases (111) · Neoplasms (111) · Leukemia (106) · Immune System Diseases (30) · Immunoproliferative Disorders (30) · Lymphatic Diseases (30) · Lymphoproliferative Disorders (30) · Bone Marrow Diseases (29) · Leukemia, Lymphoid (26) · Pathological Conditions, Signs and Symptoms (17) · Pathologic Processes (15) · Disease Attributes (12)
Cytarabine (10) · venetoclax (10) · Palliative Care (7) · Azacitidine (6) · Granulocyte Colony-Stimulating Factor (5) · Busulfan (4) · Specimen Handling (4) · Blood Specimen Collection (3) · Cyclophosphamide (3) · Educational Status (3) · Idarubicin (3) · Injections (3) · Standard of Care (3) · fludarabine (3) · Aclarubicin (2)
Massachusetts General Hospital (5) · University of Rochester (5) · Institute of Hematology & Blood Diseases Hospital, China (4) · Dana-Farber Cancer Institute (3) · Fred Hutchinson Cancer Center (3) · Institut Paoli-Calmettes (3) · University of Washington (3) · CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. (2) · Centre Leon Berard (2) · Children's Hospital of Philadelphia (2) · City of Hope Medical Center (2) · Duke University (2) · First Affiliated Hospital of Zhejiang University (2) · Gruppo Italiano Malattie EMatologiche dell'Adulto (2) · Huihan Wang (2)
United States (48) · China (29) · France (13) · Italy (4) · Australia (2) · Belgium (2) · Canada (2) · Denmark (2) · Norway (2) · Sweden (2) · Austria (1) · Egypt (1) · Estonia (1) · Finland (1) · Germany (1)
Areej El-Jawahri, MD (4) · Jianxiang Wang, MD (3) · Kah Poh Loh (3) · Damiano Rondelli, MD (2) · Huihan Wang, Doctor (2) · Xingbing Wang (2) · Adam Binder, MD (1) · Alessandro Flavio Ferri (1) · Alexi Vasbinder, PhD, RN (1) · Anna Halpern (1) · Anna Halpern, MD (1) · Antonio Curti (1) · Ashley Bryant, PhD, RN (1) · Bei Liu, MD (1)
PMID 38429079, PMID 14669295, PMID 17891547, PMID 19918155, PMID 20085940, PMID 21664296, PMID 22609885, PMID 25234438, PMID 27760758, PMID 28533058, PMID 31038430, PMID 31518304, PMID 31623675, PMID 33159220, PMID 33331857, PMID 34077243, PMID 34749008, PMID 35689676, PMID 35771552, PMID 35777413, PMID 36521100, PMID 36655338, PMID 37806074, PMID 37957175, PMID 38088668, PMID 38102639, PMID 38336521, PMID 38553062, PMID 38772898, PMID 38935428, PMID 41894682, PMID 41986965, PMID 42263667, PMID 42275539
P30CA015704 (2), 2018 (1), KL2TR002317 (1), P30CA012197 (1), P30CA033572 (1), R34NR019131 (1), U24HL138660 (1)